MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Autonomic dysfunction in early Parkinson’s disease: a prospective study

    I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To define prevalence, severity, and predictors of dysautonomia symptoms in patients with Parkinson's disease (PD) recruited at the Hoehn and Yahr stage 1 prospectively followed for three years.…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in Parkinson’s disease

    A. Amara, K. Wood, A. Joop, R. Memon, J. Pilkington, M. Bamman, C. Hurt (Birmingham, AL, USA)

    Objective: Investigate relationship between cognitive performance and mobility in persons with Parkinson’s disease (PD). Background: Persons with PD experience both motor and non-motor symptoms. Two…
  • 2019 International Congress

    BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

    Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

    Objective: The aim of the current study is to directly compare performance in recognition of facial and bodily emotions. Background: Patients with Parkinson´s disease (PD)  show…
  • 2019 International Congress

    Mild Cognitive Impairment in Young Onset Parkinson Disease

    A. Troster, C. Schweer (Phoenix, AZ, USA)

    Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…
  • 2019 International Congress

    Pathological role of GBA2 in GBA1-related disorder

    E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

    Objective: This study was performed to determine the pathological role of the non-lysosomal β-Glucosidase (GBA2) in the CNS in Gaucher’s disease (GD) and GBA1-related Parkinson's…
  • 2019 International Congress

    Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

    F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

    Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…
  • 2019 International Congress

    Translation, validation, diagnostic accuracy and reliability of a Parkinson´s disease screening questionnaire in three countries in Africa: A progress report and preliminary data

    NU. Okubadejo, A. Shalash, J. Doumbe, C. Tanner, R. Walker, C. Dotchin, OP. Agabi, E. Hamid, A. Helmi, H. Elrassas, T. Rushdi, O. Ojo, O. Oguntunde, S. Calvo, L. Aguado, E. Cubo (Burgos, Spain)

    Objective: To translate and adapt the PD screening questionnaire into French and Arabic for use in Africa. To determine the diagnostic accuracy of the English,…
  • 2019 International Congress

    Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

    T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether GBA mutations are associated with structural abnormalities in a cohort of GBA mutation carriers with and without manifested PD.…
  • 2019 International Congress

    Karl Marx, Rosa Luxemburg, and Deep Brain Stimulation: is there a connection?

    M. Hariz, P. Krack, A. Lees (Umea, Sweden)

    Objective: To investigate possible reasons behind some practices of deep brain stimulation (DBS) hardware providers. Background: The global success of DBS in movement disorders has…
  • 2019 International Congress

    Does Deep Brain Stimulation in Parkinson’s Disease Change Disease Progression in the Long Run?

    A. Løkkegaard, B. Jespersen, M. Karlsborg, A. Clausen, S. Jensen, B. Thomsen (Copenhagen, Denmark)

    Objective: This is one of the first studies investigating the progression of disease and mortality of patients with Parkinson’s Disease (PD) 8-15 years after Deep…
  • « Previous Page
  • 1
  • …
  • 195
  • 196
  • 197
  • 198
  • 199
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley